Overview of Valsartan (NDC: 51660-142)
Valsartan, with the National Drug Code (NDC) 51660-142, is a prescription drug categorized under the generic name Valsartan. It is manufactured and distributed by Ohm Laboratories Inc. and is available in the form of a film-coated oral tablet[1].
Market Context
Life Sciences Industry Trends
The life sciences industry, including pharmaceuticals, is undergoing significant transformations driven by digital innovation, regulatory changes, and market dynamics. Pricing and access to drugs are among the top concerns for industry executives, with nearly half expecting these factors to significantly impact their strategies in 2025[3].
Generic Drugs and Patent Cliff
The rise of generic drugs and biosimilars is a key trend, with 37% of executives viewing competition from these as a top concern. The patent cliff, where high-revenue products lose exclusivity, is also a significant issue, with over $300 billion in sales at risk through 2030. This could drive interest in mergers and acquisitions, which 77% of surveyed executives expect to increase in 2025[3].
Market Analysis for Valsartan
Market Position
Valsartan, an angiotensin II receptor antagonist, is used primarily to treat high blood pressure and heart failure. As a generic drug, it competes in a crowded market where pricing is a critical factor.
Pricing Dynamics
Generic drugs like Valsartan are generally priced lower than their brand-name counterparts. However, pricing can fluctuate based on market demand, competition, and regulatory changes. The cost of production, research and development expenses, and market competition play significant roles in determining the price of generic drugs.
Regulatory Environment
The FDA's regulatory framework, including the National Drug Code (NDC) directory, ensures that all finished drug products, including generics like Valsartan, are properly listed and monitored. This regulatory oversight helps maintain drug safety and efficacy standards[5].
Price Projections
Current Pricing
While specific current pricing data for NDC 51660-142 is not provided, generic drugs typically see stable or slightly decreasing prices over time due to increased competition.
Future Trends
- Competition and Patent Expirations: As more patents expire, the market for generic drugs is expected to grow, potentially leading to increased competition and downward pressure on prices.
- Regulatory Changes: Changes in regulatory environments, such as those related to the Inflation Reduction Act or shifts in FDA interpretations, could impact pricing strategies and access to drugs[3].
- Market Demand: The demand for hypertension and heart failure treatments is likely to remain steady or increase, given the prevalence of these conditions. However, this demand can also attract more competitors, affecting pricing.
Impact of Technological Advances
Drug Discovery and Development
Advances in drug discovery technologies, such as high-throughput screening and bioanalytical instruments, are expected to grow significantly, with the global market projected to reach $197 billion by 2029. These technologies can improve the efficiency and cost-effectiveness of drug development, potentially influencing the pricing of generic drugs like Valsartan[4].
AI and Personalized Medicine
The integration of AI and the push for personalized medicine are expected to enhance operational efficiencies and drive innovation. While these advancements are more likely to impact new drug development, they could also influence the broader pharmaceutical market, including generics, by setting new standards for efficacy and safety[3][4].
Key Takeaways
- Market Competition: The generic drug market, including Valsartan, is highly competitive, with pricing influenced by numerous competitors.
- Regulatory Environment: FDA regulations and changes in regulatory interpretations can impact pricing and access to drugs.
- Technological Advances: Advances in drug discovery and development technologies can influence the cost and efficiency of producing generic drugs.
- Demand and Prevalence: The steady demand for hypertension and heart failure treatments ensures a consistent market for Valsartan.
FAQs
1. What is Valsartan (NDC: 51660-142)?
Valsartan is a generic prescription drug used to treat high blood pressure and heart failure, distributed by Ohm Laboratories Inc.
2. How does the regulatory environment impact Valsartan pricing?
The FDA's regulatory framework ensures drug safety and efficacy, and changes in regulations can affect pricing strategies and access to drugs.
3. What are the key trends affecting the life sciences industry in 2025?
Pricing and access to drugs, competition from generic drugs and biosimilars, and the patent cliff are significant trends.
4. How do technological advances in drug discovery impact generic drugs like Valsartan?
Technological advances can improve the efficiency and cost-effectiveness of drug development, potentially influencing the pricing of generic drugs.
5. What is the projected market growth for drug discovery technologies?
The global market for drug discovery technologies is expected to grow from $111.9 billion in 2024 to $197 billion by 2029, at a CAGR of 12%[4].
Sources
- FDA.report - NDC 51660-142 Oral Tablet, Film Coated VALSARTAN
- DrugPatentWatch - Latest drug prices and trends for NDC 51672-1387
- Deloitte Insights - 2025 life sciences outlook
- ResearchAndMarkets.com - Drug Discovery Technologies Global Research Report 2024
- FDA - National Drug Code Directory
